Literature DB >> 27065675

Postoperative Morbidity and Mortality Following D2 Gastrectomy-an Audit of 456 Cases.

Bhanu Jayanand Sunil1, Ramakrishnan Ayloor Seshadri1, Vikash Mahajan2, Hemanth Raj Ellusami1.   

Abstract

BACKGROUND: D2 gastrectomy is routinely performed in Japanese centres for carcinoma stomach with low morbidity and mortality. There were concerns in Western centres with regard to D2 gastrectomy in view of high morbidity and mortality rates. This study was aimed to study the postoperative morbidity and mortality following D2 gastrectomy for carcinoma stomach in a high volume centre in India.
METHODS: It was a retrospective analysis of all the patients who underwent D2 gastrectomy from 1991 to 2010.
RESULTS: D2 gastrectomy was performed in 456 patients during this period. Respiratory events were the most common cause of morbidity in the study group (2.4 %). Male gender (p = 0.007), presence of gastric outlet obstruction (p = 0.01) and pathological T4 (p = 0.05) independently predicted increased post operative morbidity in multivariate analysis. The morbidity and mortality rates declined with increase in hospital volume and experience of the surgeon.
CONCLUSION: D2 gastrectomy for carcinoma stomach can be performed safely in specialized centres with low morbidity and mortality rates.

Entities:  

Keywords:  Carcinoma stomach; D2 gastrectomy; Morbidity; Mortality

Year:  2015        PMID: 27065675      PMCID: PMC4811820          DOI: 10.1007/s13193-015-0440-x

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  34 in total

1.  Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer.

Authors:  A Gil-Rendo; J L Hernández-Lizoain; F Martínez-Regueira; A Sierra Martínez; F Rotellar Sastre; M Cervera Delgado; V Valentí Azcarate; C Pastor Idoate; J Alvarez-Cienfuegos
Journal:  Clin Transl Oncol       Date:  2006-05       Impact factor: 3.405

2.  Incidence and risk factors for hospital-acquired pneumonia after surgery for gastric cancer: results of prospective surveillance.

Authors:  Yasuhiko Mohri; Hitoshi Tonouchi; Chikao Miki; Minako Kobayashi; Masato Kusunoki
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

3.  Prolonged antibiotic prophylaxis longer than 24 hours does not decrease surgical site infection after elective gastric and colorectal surgery.

Authors:  Taketoshi Suehiro; Teijiro Hirashita; Shinichiro Araki; Takashi Matsumata; Soichi Tsutsumi; Erito Mochiki; Hiroyuki Kato; Takayuki Asao; Hiroyuki Kuwano
Journal:  Hepatogastroenterology       Date:  2008 Sep-Oct

4.  Risk factors for operative morbidity and mortality in gastric cancer patients undergoing total gastrectomy.

Authors:  Dao-Jun Gong; Chao-Feng Miao; Qi Bao; Ming Jiang; Li-Fang Zhang; Xiao-Tao Tong; Li Chen
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

5.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

6.  Is gastric carcinoma different between Japan and the United States?

Authors:  Y Noguchi; T Yoshikawa; A Tsuburaya; H Motohashi; M S Karpeh; M F Brennan
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

7.  Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach.

Authors:  M Sierzega; P Kolodziejczyk; J Kulig
Journal:  Br J Surg       Date:  2010-07       Impact factor: 6.939

8.  Postoperative complications following gastrectomy for gastric cancer during the last decade.

Authors:  Daisuke Ichikawa; Hideaki Kurioka; Tomohiro Yamaguchi; Hiroshi Koike; Kazuma Okamoto; Eigo Otsuji; Koichi Shirono; Yasuhiro Shioaki; Eito Ikeda; Fumitaka Mutoh; Hisakazu Yamagishi
Journal:  Hepatogastroenterology       Date:  2004 Mar-Apr

9.  Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

Authors:  Takeshi Sano; Mitsuru Sasako; Seiichiro Yamamoto; Atsushi Nashimoto; Akira Kurita; Masahiro Hiratsuka; Toshimasa Tsujinaka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura; Kunio Okajima
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

10.  Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.

Authors:  M Degiuli; M Sasako; M Calgaro; M Garino; F Rebecchi; M Mineccia; D Scaglione; D Andreone; A Ponti; F Calvo
Journal:  Eur J Surg Oncol       Date:  2004-04       Impact factor: 4.424

View more
  2 in total

1.  The Predictive and Prognostic Factors in Patients with Gastric Cancer Accompanied by Gastric Outlet Obstruction.

Authors:  Hongliang Zu; Huiling Wang; Chunfeng Li; Wendian Zhu; Yingwei Xue
Journal:  Gastroenterol Res Pract       Date:  2020-07-25       Impact factor: 2.260

2.  Feasibility and Safety of Early Oral Feeding in Patients with Gastric Cancer After Radical Gastrectomy.

Authors:  Toshiki Shinohara; Yoshiaki Maeda; Ryota Koyama; Nozomi Minagawa; Jun Hamaguchi; Tomonori Hamada
Journal:  Indian J Surg Oncol       Date:  2019-11-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.